Paraventricular nucleus injections of naloxone methiodide inhibit NPY's effects on energy substrate utilization

NeuroReport

Volumn 11, Issue 4, 2000, Pages 733-735

  Currie, Paul J ^a   Coscina, Donald V ^b   Moretti, John ^b   Avellino, Maria D ^a  

^a Barnard College of Columbia University   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Indirect calorimetry; Metabolism; Naloxone methiodide; Neuropeptide Y; Opioid receptor antagonism; Paraventricular nucleus; Respiratory quotient

Indexed keywords

17 METHYLNALOXONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BROWN ADIPOSE TISSUE; CALORIMETRY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENERGY CONSUMPTION; ENERGY EXPENDITURE; ENZYME ACTIVITY; FOOD INTAKE; HORMONE RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY QUOTIENT; THALAMUS MIDLINE NUCLEUS; THERMOGENESIS;

EID: 0034689467     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200003200-00016     Document Type: Article

References (31)

1. 1. Currie PJ and Coscina DV. NeuroReport 8, 3759-3762 (1997).
2. 2. Currie PJ, Saxena N and Tu AY. NeuroReport 10, 3033-3036 (1999).
3. 3. Currie PJ and Coscina DV. Brain Res 737, 238-242 (1996).
4. 4. Leibowitz SF and Alexander JT. Peptides 12, 1251-1260 (1991).
5. 5. Stanley BG and Leibowitz SF. Proc Natl Acad Sci USA 82, 3940-3943 (1985).
6. 6. DeQuidt ME and Emson PC. Neuroscience 18, 545-618 (1986).
7. 7. Stanely BG, Kyrkouli SE, Lampert S et al. Peptides 7, 1189-1192 (1986).
8. 8. Beck B, Jhanwar-Uniyal M and Burlet M. Brain Res 528, 245-249 (1990).
9. 9. Kalra SP, Dube MG and Sahu A et al. Proc Natl Acad Sci USA 88, 10931-10935.
10. 10. Wahlestedt C, Skagerber G, Edman R et al. Brain Res 417, 33-38 (1987).
11. 11. Abe M, Saito M, and Shimazu T. Biomed Res 10, 431-436 (1989).
12. 12. Billington CJ, Briggs JE, Grace M et al. Am J Physiol 260, R321-R327 (1991).
13. 13. Billington CJ, Briggs JE, Harker S et al. Am J Physiol 266, R1765-R1770 (1994).
14. 14. Currie PJ and Coscina DV. Peptides 16, 599-604 (1995).
15. 15. Currie PJ and Coscina DV. Brain Res 803, 212-217 (1998).
16. 16. Egawa M, Yoshimatsu H and Bray GA. Am J Physiol 264, R109-R115 (1993).
17. 17. Gosnell BA, Morely JE and Levine AS. Brain Res 369, 177-184 (1986).
18. 18. Woods JS and Leibowitz SF. Pharmacol Biochem Behav 23, 431-438 (1985).
19. 19. McLean S and Hoebel BG. Peptides 4, 287-292 (1983).
20. 20. Holtzman SG. Life Sci 24, 219-226 (1979).
21. 21. Levine AS, Grace M and Billington CJ. Pharmacol Biochem Behav 36, 409-412 (1990).
22. 22. Schick RR, Schusdziarra V, Nussbaumer C et al. Brain Res 552, 232-239 (1991).
23. 23. Kotz CM, Grace MK, Briggs J et al. J Clin Invest 96, 163-170 (1995).
24. 24. Paxinos G and Watson C. The Rat Brain in Stereotaxic Coordinates. New York: Academic Press, 1998.
25. 25. Kleiber M. The Fire of Life: An Introduction to Animal Energetics. New York: Robert R. Krieger, 1975.
26. 26. Leibowitz SF, Xuereb M and Kim T. NeuroReport 3, 1023-1026 (1992).
27. 27. Leibowitz SF, Sladek C, Spencer L et al. Brain Res Bull 21, 905-912 (1988).
28. 28. Moltz JH and MacDonald JK. Peptides 6, 1155-1159 (1985).
29. 29. Menendez JA and Atrens DM. Pharmacol Biochem Behav 34, 765-768 (1989).
30. 30. Chang CL, Tsai YC, Lin SS et al. Ma Tsui Hsueh Tsa Chi 30, 147-152 (1992).
31. 31. Pages N, Orosco M, Fournier C et al. Gen Pharmacol 22, 943-947 (1991).